The use of erythropoietins in oncology

The editorial article presents information about the problem of the use of erythropoietins in anemia in cancer patients in conjunction with the results of Cochrane systematic reviews the gold standard of the quality of evidence-based medical information.

Guardado en:

Detalles Bibliográficos
Autores principales:	Liliya E. Ziganshina, Irina V. Poddubnaia, Dmitrii A. Sychev
Formato:	article
Lenguaje:	RU
Publicado:	IP Habib O.N. 2021
Materias:	erythropoietin darbepoietin malignant neoplasms cochrane cochrane russia cochrane library anemia safety Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/3f5c3e7add3f4c4e9db951e6070ae58f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:3f5c3e7add3f4c4e9db951e6070ae58f
record_format	dspace
spelling	oai:doaj.org-article:3f5c3e7add3f4c4e9db951e6070ae58f2021-11-30T16:55:01ZThe use of erythropoietins in oncology1815-14341815-144210.26442/18151434.2021.2.201001https://doaj.org/article/3f5c3e7add3f4c4e9db951e6070ae58f2021-08-01T00:00:00Zhttps://modernonco.orscience.ru/1815-1434/article/viewFile/77847/58444https://doaj.org/toc/1815-1434https://doaj.org/toc/1815-1442The editorial article presents information about the problem of the use of erythropoietins in anemia in cancer patients in conjunction with the results of Cochrane systematic reviews the gold standard of the quality of evidence-based medical information.Liliya E. ZiganshinaIrina V. PoddubnaiaDmitrii A. SychevIP Habib O.N.articleerythropoietindarbepoietinmalignant neoplasmscochranecochrane russiacochrane libraryanemiasafetyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282RUСовременная онкология, Vol 23, Iss 2, Pp 248-250 (2021)
institution	DOAJ
collection	DOAJ
language	RU
topic	erythropoietin darbepoietin malignant neoplasms cochrane cochrane russia cochrane library anemia safety Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	erythropoietin darbepoietin malignant neoplasms cochrane cochrane russia cochrane library anemia safety Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Liliya E. Ziganshina Irina V. Poddubnaia Dmitrii A. Sychev The use of erythropoietins in oncology
description	The editorial article presents information about the problem of the use of erythropoietins in anemia in cancer patients in conjunction with the results of Cochrane systematic reviews the gold standard of the quality of evidence-based medical information.
format	article
author	Liliya E. Ziganshina Irina V. Poddubnaia Dmitrii A. Sychev
author_facet	Liliya E. Ziganshina Irina V. Poddubnaia Dmitrii A. Sychev
author_sort	Liliya E. Ziganshina
title	The use of erythropoietins in oncology
title_short	The use of erythropoietins in oncology
title_full	The use of erythropoietins in oncology
title_fullStr	The use of erythropoietins in oncology
title_full_unstemmed	The use of erythropoietins in oncology
title_sort	use of erythropoietins in oncology
publisher	IP Habib O.N.
publishDate	2021
url	https://doaj.org/article/3f5c3e7add3f4c4e9db951e6070ae58f
work_keys_str_mv	AT liliyaeziganshina theuseoferythropoietinsinoncology AT irinavpoddubnaia theuseoferythropoietinsinoncology AT dmitriiasychev theuseoferythropoietinsinoncology AT liliyaeziganshina useoferythropoietinsinoncology AT irinavpoddubnaia useoferythropoietinsinoncology AT dmitriiasychev useoferythropoietinsinoncology
_version_	1718406439274283008

The use of erythropoietins in oncology

Ejemplares similares